Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss
- PMID: 9709967
- DOI: 10.1210/jcem.83.8.5026
Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss
Abstract
In view of the recent demonstration that obesity in animals and humans is associated with an increase in tumor necrosis factor-alpha (TNFalpha) expression, that this expression falls with weight loss, and that TNFalpha may specifically inhibit insulin action, the possibility that TNFalpha may be a mediator of insulin resistance has been raised. We have undertaken this study to investigate whether serum TNFalpha concentrations are elevated in obese subjects, whether they fall after weight loss, and whether this fall parallels the fall in insulin release after glucose challenge. Obese patients (age range: 25-54, weight mean +/- SD: 96.4 +/- 13.8 kg, body mass index: 35.7 +/- 5.6 kg/m2) were started on a diet program. The mean weight fell to 84.5 +/- 11.3 (P < 0.0001) and body mass index to 31.3 +/- 4.9 (P < 0.0001). Plasma TNFalpha concentrations were markedly elevated in the obese (3.45 +/- 0.16 pg/mL), when compared with controls (0.72 +/- 0.28 pg/mL), and fell significantly (2.63 +/- 1.40 pg/mL) after weight loss (P < 0.02). The magnitude of insulin release after glucose (75 g) challenge (area under the curve) also fell significantly (P < 0.01) after weight loss. The magnitude of weight loss and fall in TNFalpha were related to basal body weight (r = 0.57, P < 0.001) and basal TNFalpha (r = 0.55, P < 0.001) concentrations, respectively, but not to each other or to the glucose-induced insulin release (area under the curve). We conclude that obesity is associated with increased plasma TNFalpha concentrations, which fall with weight loss. Because circulating TNFalpha may mediate insulin resistance in the obese, a fall in TNFalpha concentrations may contribute to the restoration of insulin resistance after weight loss, Thus, TNFalpha may be an important circulating cytokine, which may provide a potentially reversible mechanism for mediating insulin resistance.
Similar articles
-
Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.Metabolism. 1999 Oct;48(10):1332-5. doi: 10.1016/s0026-0495(99)90277-9. Metabolism. 1999. PMID: 10535400
-
Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94. doi: 10.1038/sj.ijo.0802187. Int J Obes Relat Metab Disord. 2003. PMID: 12532159
-
Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.Cardiovasc Diabetol. 2006 Jun 27;5:14. doi: 10.1186/1475-2840-5-14. Cardiovasc Diabetol. 2006. PMID: 16803616 Free PMC article.
-
Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia.Metabolism. 2006 Feb;55(2):271-6. doi: 10.1016/j.metabol.2005.08.022. Metabolism. 2006. PMID: 16423637
-
The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation.J Clin Endocrinol Metab. 2001 Jan;86(1):355-62. doi: 10.1210/jcem.86.1.7150. J Clin Endocrinol Metab. 2001. PMID: 11232024
Cited by
-
Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus.Clin Gastroenterol Hepatol. 2012 Jul;10(7):728-34; quiz e61-2. doi: 10.1016/j.cgh.2012.03.007. Epub 2012 Mar 17. Clin Gastroenterol Hepatol. 2012. PMID: 22433923 Free PMC article.
-
Impact of Intermittent Fasting on Metabolic Syndrome and Periodontal Disease-A Suggested Preventive Strategy to Reduce the Public Health Burden.Int J Environ Res Public Health. 2022 Nov 5;19(21):14536. doi: 10.3390/ijerph192114536. Int J Environ Res Public Health. 2022. PMID: 36361416 Free PMC article. Review.
-
Obesity and immune status in children.Curr Opin Pediatr. 2020 Dec;32(6):805-815. doi: 10.1097/MOP.0000000000000953. Curr Opin Pediatr. 2020. PMID: 33105275 Free PMC article. Review.
-
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.Rev Endocr Metab Disord. 2010 Mar;11(1):61-74. doi: 10.1007/s11154-010-9134-4. Rev Endocr Metab Disord. 2010. PMID: 20186491 Free PMC article. Review.
-
Dysregulation of maternal serum adiponectin in preterm labor.J Matern Fetal Neonatal Med. 2009 Oct;22(10):887-904. doi: 10.1080/14767050902994655. J Matern Fetal Neonatal Med. 2009. PMID: 19579094 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical